INTRODUCTION
Streptococcus pneumoniae bacteria live mostly in the nasopharynx of young children without causing harm, but when they do invade they cause serious diseases such as pneumonia, sepsis and meningitis. The antigenic and biochemical properties of the polysaccharide capsule are used to characterize Streptococcus pneumoniae strains into over 90 distinct serotypes. Some serotypes such as 1, 4, 5, 7F and 14 have been associated with invasive disease, whilst others such as 6A, 6B, 15, 18C, 19F and 23F are more efficient at colonizing the nasopharynx (Brueggemann et al., 2004; Hanage et al., 2005; Kronenberg et al., 2006; Sandgren et al., 2004) . However, when the latter do invade they cause more severe disease than serotypes which are commonly associated with invasive disease (Sjostrom et al., 2006) . Bättig et al. (2006) have recently shown a correlation between the lag phase during in vitro growth and serotype-specific invasiveness. Understanding the characteristics of different serotypes is of great interest in an era in which serotype selection is influenced by vaccination.
The polysaccharide capsule is a major virulence factor of S. pneumoniae. It protects the bacteria from phagocytosis after invasion. However, expression of a capsule reduces bacterial attachment to respiratory epithelial cells and may therefore hamper colonization (Adamou et al., 1998; Cundell et al., 1995; Weiser et al., 1994) . Hammerschmidt et al. (2005) have shown by electron microscopy that bacteria in intimate contact with epithelial cells have a thinner capsule layer, i.e. they may down-regulate capsule expression in order to enhance adherence. It has been suggested that, at least in serotype 3, polysaccharide chain length can be modulated by sugar concentration in the environment (Ventura et al., 2006) .
The polysaccharide capsule of most serotypes of S. pneumoniae is encoded by a gene cluster located between dexB and aliA. Capsule operons of different serotypes show a similar structure with some conservation, particularly within the first four genes, downstream of which are the serotype-specific genes (Garcia et al., 1999; Jiang et al., 2001; Bentley et al., 2006) . The first gene, cpsA, is the most IP: 54.70.40.11
On: Thu, 27 Dec 2018 21:23:26 conserved and may have a role in regulation of capsule expression (Guidolin et al., 1994) .
Expression studies of cpsA have shown conflicting results. Transcription of cpsA has been shown by RT-PCR to be upregulated fourfold in bacteria recovered 24 h after intraperitoneal infection compared to expression in vitro (Ogunniyi et al., 2002) . In contrast, a microarray analysis found no increase in cpsA expression in bacteria from the blood of mice compared to bacteria grown in vitro (Orihuela et al., 2004) , and no difference in cpsA expression was found among bacteria isolated from the nasopharynx, lungs and blood of mice infected intranasally (LeMessurier et al., 2006) .
Here, we aimed to compare cpsA expression in vitro in clinical isolates representing pneumococcal serotypes associated with invasiveness and serotypes associated with nasopharyngeal colonization.
METHODS
Bacterial strains. Clinical isolates of S. pneumoniae were randomly selected from two nationwide surveillance programmes that collected nasopharyngeal and invasive isolates (Mühlemann et al., 2003; Hathaway et al., 2004; Kronenberg et al., 2006) . Both surveillance programmes started in 1998 and are ongoing, with short interruptions between January 2000 and March 2002. Capsular serotypes were determined by the Quellung reaction, as described previously (Mühlemann et al., 2003; Hathaway et al., 2004) or the 'agglutination reaction' (Statens Serum Institut, Copenhagen, Denmark) . A total of 43 encapsulated S. pneumoniae isolates representing 14 serotypes (1, 4, 5, 6A, 6B, 7F, 8, 9V, 14, 15, 18C, 19F, 23F and 33) were used. For each serotype two to six different isolates were included. Isolates from sterile body sites and from the nasopharynx were chosen.
Bacterial culture. Bacteria were stored at 280 uC using Protect bacterial preservers (Technical Service Consultants). Bacteria were grown on Columbia sheep blood agar (CSBA) plates at 37 uC in a 5 % CO 2 atmosphere. An overnight culture was prepared with three to 10 colonies in 5 ml brain heart infusion (BHI; Becton Dickinson) containing 5 % fetal calf serum (FCS; Biochrom). A 100 ml sample from the overnight culture was subcultured at 37 uC in 5 ml BHI with 5 % FCS and grown to OD 600 0.5-0.7 (measured using a Perkin Elmer Lambda 2 spectrophotometer with cuvettes of 1 cm path length). After transferring 200 ml of this culture into a tube containing 10 ml BHI, the bacteria were cultured to OD 600~0 .6, and were therefore at the end of exponential growth, unless otherwise stated. When anaerobic conditions were required, they were achieved using AnaeroGen sachets (Oxoid) according to the manufacturer's instructions, by incubating within a 37 uC room the bacterial cultures in tubes with loosened lids in sealed containers that contained an AnaeroGen sachet. For ambient oxygen conditions, the bacterial cultures in tubes with loosened lids were also incubated in the 37 uC room, but without the sealed container or AnaeroGen sachet. No cultures were shaken. In order to determine whether the strains were of an opaque or transparent phenotype, they were plated onto tryptic soy plates containing 1 % agar onto which 5000 U catalase (Sigma) had been spread, and viewed by stereomicroscopy using oblique transmitted illumination, as described elsewhere (Weiser et al., 1994) .
PFGE. DNA was isolated as described previously (Stutzmann Meier et al., 2003) and PFGE typing was done on all isolates, as described elsewhere (Léchot et al., 2001) , by use of SmaI for restriction digestion of chromosomal DNA. PFGE patterns were analysed with Bionumerics software (version 3.0, Applied Maths). Patterns were clustered by the unweighted pair group method with arithmetic mean (UPGMA) and a dendrogram was generated from a similarity matrix calculated using the Dice similarity coefficient with an optimization of 1.0 % and a tolerance of 1.5 %.
Epidemiological data on invasive potential and carriage prevalence of pneumococcal serotypes. Serotypes were grouped as 'invasive' or 'colonizers' based on previous studies with serotype 14 as a fixed reference. This serotype and any with a higher odds ratio (OR) were considered invasive and all others as colonizing. ORs for the invasive potential of individual serotypes were kindly provided by Dr A. Brueggemann, University of Oxford (Brueggemann et al., 2004) , or obtained from our local analysis (Kronenberg et al., 2006) .
RNA isolation. When the bacteria reached OD 600 0.6, twice the culture volume of RNAprotect (Qiagen) was added to stop further transcription and prevent RNA degradation. After vortexing and a 5 min incubation at room temperature, the bacteria were pelleted by centrifugation for 10 min at 5000 g. The pellet was resuspended in 200 ml TE buffer (10 mM Tris/HCl, 1 mM EDTA, pH 8) containing 600 mg lysozyme. After 10 min at room temperature with repeated vortexing, 700 ml RLT buffer (Qiagen RNeasy Mini kit) containing b2-mercaptoethanol was added, and the tubes were vortexed. The mixture was transferred to a 1.5 ml tube containing 0.05 g 100 mm acid-washed glass beads (Sigma) and vibrated for 10 min at halfmaximum speed using a Mickle Vibratory Tissue Disintegrator (Mickle Laboratory Engineering). The mixture was then centrifuged and RNA extracted from the supernatant using a Qiagen RNeasy Mini kit according to the manufacturer's instructions. The RNA recovered was treated with Dnase I (Stratagene Europe), according to the manufacturer's instructions, to remove any contaminating DNA.
Quantification of gene expression. A 1 mg volume of total RNA of each sample was reverse-transcribed to cDNA using Superscript II (Amersham) and random hexamer primers, according to the supplier's protocol. Quantification of gene expression was achieved by real-time RT-PCR using TaqMan primers and probes created by the Assay-by-Design Service of Applied Biosystems, based on the most conserved regions of the first gene of the capsule operon in different serotypes of S. pneumoniae. The 16S rRNA gene was used as an endogenous control. The primer sequences were: cpsA forward primer, 59-CTCTTTGCAGTACAGCAGTTTGTTG-39; reverse primer, 59-CTATCTGCTAAAACAGCGACACTGA-39; probe, 6-carboxyfluorescein (6-FAM)-ACTGACCAATCGTTTAAATG-minor groove binder (MGB); 16S forward primer, 59-GACGATACATAGCCGACC-TGAGA-39; reverse primer, 59-GTAGGAGTCTGGGCCGTGTCT-39; probe, 6-FAM-CCAGTGTGGCCGATC-MGB. The cDNA was diluted 25-fold in the assay and a reverse-transcription-negative control was performed for every sample. Real-time RT-PCR was performed in 96well plates using an ABI PRISM 7000 Sequence Detection System (Applied Biosystems) and the relative gene expression for the different serotypes was calculated from the crossing threshold (Ct) value according to the manufacturer's protocol (2 2DDCt ) after normalization using the 16S rRNA endogenous control.
Quantification of capsule. The amount of capsule was determined using the Stains-all assay (Sigma) for detecting acidic polysaccharides (Hammerschmidt et al., 2005) . The bacteria were cultured in BHI to OD 600 0.6 under aerobic or anaerobic conditions (see above), then 5 ml was centrifuged for 10 min at 5000 g, washed with PBS and resuspended in 0.5 ml 0.85 % NaCl. A 10 ml volume was removed to make dilutions in PBS for plating out to quantify the number of bacteria. To the remaining bacterial suspension, 2 ml of a solution containing 20 mg 1-ethyl-2(3-(1-ethylnaphthho-(1,2-d)thiazolin-2ylidene)-2methylpropenyl) naphthho-(1,2-d 
RESULTS
Invasive serotypes express more cpsA than colonizing serotypes in vitro
For each of 43 isolates, representing 14 serotypes, PFGE was performed; Fig. 1 shows that each serotype was represented by isolates with at least two different patterns, demonstrating heterogeneity within the bacterial population used. All strains were predominantly of a transparent phenotype (between 61 and 97 % of colonies). For each isolate, cpsA expression was determined by real-time RT-PCR in cultures grown in BHI to OD 600 0.6 under ambient oxygen conditions. A serotype 6B isolate was found to have the lowest cpsA expression and was given an arbitrary value of 1, and cpsA expression values for all other strains were expressed as a multiple of the value for this isolate in order to compare cpsA expression levels between isolates. Pneumococcal serotypes have been shown to differ in their propensity to be carried in the nasopharynx or to be associated with invasive disease. Expression of cpsA was plotted against serotype-specific carriage prevalence values from an international study (Brueggemann et al., 2004) and a local (Swiss) study (Kronenberg et al., 2006) . The serotype-specific carriage prevalence correlated inversely with cpsA expression using values from Brueggemann et al.
(2004) (P50.005, Fig. 2a ) or Kronenberg et al. (2006) (P50.03, Fig. 2b) . The likelihood of a serotype or group being associated with invasive disease rather than with colonization of the nasopharynx can be expressed as an OR (Brueggemann et al., 2004) . Brueggemann et al. (2004) used serotype 14 as a reference group and considered serotypes with ORs greater than that of serotype 14 to be invaders and those with a lower OR to be colonizers. We applied this method of division into invaders and colonizers to our data according to Fig. 2d ). No significant difference in mean cpsA expression was detected between isolates collected from a sterile site (mean 4.78, SD 3.84) and those collected from the nasopharynx (mean 4.82, SD 2.79;
P50.96). This was also true when mean cpsA expression was compared between isolates collected from a sterile site and those collected from the nasopharynx within groups of invader serotypes and groups (mean 6.3, SD 4.46, vs mean 7.22, SD 2.51; P50.61) and colonizer serotypes and groups (mean 2.70, SD 0.83, vs mean 3.29, SD 2.17; P50.31). The number of isolates was, however, too small to allow for a comparison of cpsA expression between different clones belonging to the same serotype or group. 
Effect of anaerobic conditions on cpsA expression
To determine whether cpsA expression was dependent on oxygen tension, expression was measured in five isolates of five different serotypes (1, 6A, 9V, 15 and 19F) under ambient oxygen and anaerobic conditions in BHI. Fig. 3 shows the association between higher cpsA expression under ambient oxygen conditions in serotypes with higher ORs (serotypes 1 and 9V) and a lower expression level for the colonizer serotypes 6A, 15 and 19F. Anaerobic conditions did not cause a significant difference in cpsA expression in any of the five serotypes tested.
The amount of acidic capsule polysaccharide produced does not depend on oxygen tension
The Stains-all assay is only suitable for measuring the amount of capsule for those serotypes which have acidic polysaccharide capsules, and so was used to determine the amount of capsule for the serotype 1 and 19F isolates cultured in BHI under ambient oxygen or anaerobic conditions to OD 600 0.6. For both serotypes there was no significant change in the amount of capsule under anaerobic conditions. (OD 640 for serotype 1 under aerobic vs anaerobic conditions: mean 0.173, SD 0.168, vs mean 0.200, SD 0.217; P50.71. OD 640 for serotype 19F under aerobic vs anaerobic conditions: mean 0.061, SD 0.038, vs mean 0.096, SD 0.042; P50.34).
Serotypes with a longer lag phase of in vitro growth tend to have higher cpsA expression
Expression of cpsA was assessed by real-time RT-PCR on RNA from clinical isolates cultured to OD 600 0.6 in BHI and correlated with the data of Bättig et al. (2006) , who measured the lag phase when the bacteria were cultured in BHI. Fig. 4 shows that there was a trend towards greater cpsA expression in strains with a longer lag phase (P50.07).
DISCUSSION
Several studies have reported an association between S. pneumoniae capsular serotype and the likelihood of isolation from a sterile anatomical site (blood, lungs or central nervous system) or from the nasopharynx Sandgren et al., 2004; Brueggemann et al., 2004; Hanage et al., 2005; Kronenberg et al., 2006) . The mechanism leading to this association is not understood.
The polysaccharide capsule protects against phagocytosis but hampers adherence to respiratory cells. Regulation of the amount of capsule produced depending on the anatomical niche might therefore be advantageous (Hammerschmidt et al., 2005) . Control of capsule expression is not well understood, except for the case of switching off capsule expression entirely by spontaneous sequence duplications or mutations in capsule genes (Waite et al., 2001 (Waite et al., , 2003 Arrecubieta et al., 1994) , or apparent replacement of capsule genes with novel aliB-like ORFs (Hathaway et al., 2004) . However, in strains with a complete capsule operon, a role for tyrosine phosphorylation of CpsD, the product of the fourth capsule operon gene, in regulation of capsular polysaccharide production has been proposed (Bender et al., 2003) . In this study the role of transcription of the capsule operon was investigated. Since the capsule operon appears to be arranged as a single transcriptional unit (Morona et al., 1997; Munoz et al., 1997) , transcription of the first gene of the capsule operon, cpsA, was measured. This study was limited to in vitro cpsA expression with quantification of capsule polysaccharide for only two isolates. We show that under in vitro conditions serotypes associated with invasive disease (expressed as the likelihood of isolation in the context of an invasive infection rather than from the nasopharynx) have on average higher cpsA expression than serotypes with high colonization prevalence. No difference was found in cpsA expression between isolates collected from a sterile site and those collected from the nasopharynx. This appears to indicate that the site of isolation does not play a role in cpsA expression. However, it must be borne in mind that the bacteria have undergone growth in vitro before RNA isolation, which may have eliminated any differences in expression that were present in vivo.
The association between cpsA expression and the invasiveness of serotypes observed in this study was stronger when the OR data from a study of local Swiss epidemiology (Kronenberg et al., 2006) were used rather than OR data from a previous study which represents the epidemiology in several other countries (Brueggemann et al., 2004) . This may reflect clonal differences within serotypes between geographical regions (Sandgren et al., 2004; Hanage et al., 2005) . For example, clone-specific differences for invasiveness within serotype 1 have been observed (Brueggemann & Spratt, 2003) . In the present study, using a clonally mixed strain collection, there was some variation in cpsA expression within serotypes between isolates with different PFGE patterns. However, to study this in detail, many isolates representing several clones of the same serotype would be needed to determine with certainty the effect of the genetic background of the isolates on cpsA expression.
In the current context of vaccine selection pressure it is especially important to identify serotypes with high invasive potential. We aimed to discover the differences between invasive and non-invasive serotypes, and suggest that one difference is their level of expression of the capsule gene cpsA. Although the obvious consequence of this might be a difference in the amount of capsule, it might also be that the capsule genes have some other role, such as in metabolism. As described recently by Bättig et al. (2006) , the capsule genes also appear to affect growth in vitro, with invasive serotypes having a longer lag phase. In this study we show that the length of lag phase tends also to correlate with relative cpsA expression at OD 600 0.6. If this translates into difficulty in growth in the nasopharynx, the bacteria could be upregulating cpsA expression as a response to stress in order to synthesize products essential for survival and growth, which may be unconnected with capsule production. However, care must be taken in extrapolating results of cpsA expression at one point in the growth curve to the length of the lag phase, and so further studies are required to clarify this relationship.
In this study with transparent clinical isolates the level of ambient oxygen had no effect on cpsA expression in either invasive or non-invasive serotypes. However, after invasion there is a predominance of the opaque phenotype (Weiser et al., 2001) and anaerobic conditions cause an increase in the amount of capsule in opaque variants. As stated by Weiser et al. (2001) , the bacteria would be exposed to the highest ambient oxygen levels when on the airway surface, but the oxygen tension encountered would be much lower during pneumonia, in blood or in the middle ear. It would be interesting to determine in further studies whether in opaque clinical isolates there is a change in the transcription of cpsA under anaerobic conditions and whether this differs between serotypes with high and low invasive potential. Fig. 4 . Expression of cpsA and in vitro growth. Expression was assessed by real-time RT-PCR of RNA from clinical isolates cultured to OD 600 0.6 in BHI. log 10 (relative cpsA expression) was plotted against the length of lag phase during in vitro growth in BHI (Bä ttig et al., 2006) . There was a trend towards higher cpsA expression in strains with a longer lag phase (P50.07).
In conclusion, in vitro expression of the first gene of the pneumococcal capsule operon, cpsA, under ambient oxygen concentrations correlates with the invasiveness of the serotype and inversely with the carriage prevalence of the serotype. No change in cpsA expression in response to a change in environmental oxygen concentration was observed in the transparent clinical isolates tested.
